arrow left
arrow right
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
						
                                

Preview

FILED: NEW YORK COUNTY CLERK 01/21/2022 03:04 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 677 RECEIVED NYSCEF: 01/21/2022 SUPREME COURT OF THE STATE OF NEW YORK NEW YORK COUNTY PRESENT: HON. ANDREW BORROK PART 53 Justice ---------------------------------------------------------------------------------X INDEX NO. 652343/2018 CRESCO LABS NEW YORK, LLC, CRESCO LABS LLC, MOTION DATE AN ILLINOIS LIMITED LIABILITY COMPANY, Plaintiff, MOTION SEQ. NO. 013 014 -v- FIORELLO PHARMACEUTICALS, INC., ERIC SIROTA, DECISION + ORDER ON SUSAN YOSS, JOHN DOES 1 - 10 MOTION Defendant. ---------------------------------------------------------------------------------X The following e-filed documents, listed by NYSCEF document number (Motion 013) 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 274, 275, 277, 541, 542, 543, 544, 545, 546, 547, 548, 549, 550, 551, 552, 553, 554, 555, 556, 557, 608 were read on this motion to/for PRECLUDE . The following e-filed documents, listed by NYSCEF document number (Motion 014) 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 276, 278, 536, 537, 538, 539, 540, 666 were read on this motion to/for PRECLUDE . Upon the foregoing documents and for the reasons set forth on the record (1.21.2022), the motions are denied. However, to the extent that Fiorello Pharmaceuticals, Inc. (Fiorello) wishes to seek discovery on the Contingent Share Escrow Agreement (the CSEA), such limited discovery will be permitted. Fiorello shall email Part 53 (sfc-part53@nycourts.gov) by January 31, 2022, to inform the court whether it seeks limited discovery on the CSEA. If an email is not received by January 31, 2022, Fiorello will have been deemed to forfeit its right to seek further discovery on the CSEA. Cresco Labs New York, LLC and Cresco Labs LLC (collectively, Cresco) shall respond to Fiorello’s demands by February 3, 2022. 652343/2018 vs. Page 1 of 2 Motion No. 013 014 1 of 2 FILED: NEW YORK COUNTY CLERK 01/21/2022 03:04 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 677 RECEIVED NYSCEF: 01/21/2022 Any additional expert report in this case must be served and filed by February 14, 2022. 1/21/2022 DATE ANDREW BORROK, J.S.C. CHECK ONE: CASE DISPOSED X NON-FINAL DISPOSITION GRANTED X DENIED GRANTED IN PART OTHER APPLICATION: SETTLE ORDER SUBMIT ORDER CHECK IF APPROPRIATE: INCLUDES TRANSFER/REASSIGN FIDUCIARY APPOINTMENT REFERENCE 652343/2018 vs. Page 2 of 2 Motion No. 013 014 2 of 2